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A rare γ-pyranopyrazole skeleton: design, one-pot
synthesis and computational study†
Muhammed Üçüncü,a Ceren Cantürk,a Erman Karakuş,a Hüseyin Zeybek,a
Uğur Bozkaya,b Emine Soydaş,c Ertan Şahinc and Mustafa Emrullahoğlu*a
Drawing upon a consecutive amide coupling and intramolecular cyclisation pathway, a one-pot, straight-
forward synthetic route has been developed for a range of pyrazole fused γ-pyrone derivatives. The
reaction mechanism proposed for the chemoselective formation of γ-pyranopyrazole is furthermore fully
supported by experimental and computational studies.
Heterocyclic compounds bearing a pyrone scaffold (e.g.,
4-pyrone or γ-pyrone) exhibit an array of biological and
pharmacological activities.1 Since the biological activity of the
pyrone ring is closely linked to the core structure’s substitution
pattern, incorporating other ring motifs into the pyrone
skeleton could greatly contribute to the parent molecule’s bio-
logical activity.2 In terms of biological diversity, constructing
ring-fused pyrone derivatives has attracted significant attention;
however, despite widespread interest in and efforts toward con-
structing new pyrone derivatives, ring-fused pyrone derivatives
remain extremely rare,3 given the lack of practical and effective
synthetic protocols and guidelines for their construction.
Representing an unusual example of a fused pyrone ring,
the pyranopyrazole ring system can participate in diverse bio-
logical activities including analgesic, anti-inflammatory,
antimicrobial, fungicidal, and cytotoxic activities.4 Certain
derivatives of pyranopyrazoles have been evaluated for their
affinity to bind with bovine brain adenosine receptors.5 At the
same time, the γ-pyranopyrazole ring system is photoactive
and apt to undergo photochemical reactions such as photo-
dimerization and photocleavage.6
The general method for preparing the known pyrano[3,2-c]
pyrazole skeleton relies on a two-step synthetic process, which
Gelin et al. have described (Fig. 1).7 Over the years, improved
versions of the method have been published,8 most of which
however still employ harsh reaction conditions (i.e., refluxing
in acetic or sulphuric acid). Deng et al. have recently intro-
duced an elegant approach to the same γ-pyranopyrazole skele-
ton that relies on a tandem cyclisation process employing
certain diazo compounds as starting materials.9 Nevertheless,
other concise methods of constructing new γ-pyrone structures
with potential biological activities continue to be in demand.
In response, we herein report a straightforward, one-pot
synthetic protocol for constructing γ-pyranopyrazoles with a
rare structural skeleton. This rare γ-pyranopyrazole skeleton
differs from the common skeleton insofar as the nitrogen of
the pyrazole ring is located on the bridge of the fused ring
system (Fig. 1). To the best of our knowledge, only one report
has described the preparation of this skeleton, namely as a
low-yield by-product that remains to be thoroughly
investigated.10
As part of our continued interest in synthesizing fluorescent
labelling molecules, we have outlined a synthetic approach for
preparing 1,5-diazabicyclo [3.3.0]octadienediones (D) (9,10-
dioxabimanes) (Scheme 1). We proposed a two-step synthetic
pathway, first involving a classical amide coupling between
pyrazolone (A) and 2-propiolic acid (B) (Scheme 1). Compound
C was anticipated to cyclize in an intramolecular hydroamina-
tion process to yield the expected bimane structure (D).
Surprisingly, however, instead of producing bimane (D),
compound C cyclized unexpectedly from the oxygen atom over
the alkyne to yield compound E: a γ-pyrone derivative fused
with a pyrazole ring. We thus experimentally investigated the
Fig. 1 Structure of γ-pyrone and γ-pyranopyrazole.
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mechanism for the chemoselective formation of γ-pyrano-
pyrazole (E) over bimane (D), the results of which were
unambiguously supported by theoretical calculations.
We commenced our investigation by optimizing the reac-
tion conditions for C–N coupling, which uses pyrazolone (1a)
and phenylpropiolic acid (2a) as the model substrates (Fig. 2).
The reaction of 1a with 2a in the presence of classical coup-
ling reagents such as dicyclohexylcarbodiimide (DCC) and
N,n-dimethyl-4-aminopyridine (DMAP) was performed in
various solvent systems and followed carefully by thin-layer
chromatography (TLC) and nuclear magnetic resonance (NMR)
spectroscopy. The efficacy of C–N bond formation greatly
depended on the nature of the solvent system. The reaction of
1a with 2a proceeded smoothly in general, though most
quickly (1 h, >95% conversion) in tetrahydrofuran (THF),
whereas the conversion time of 1a in alternative solvent
systems (e.g. DCM and CH3CN) was quite longer (7–16 h).
When 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI,
1.2 equiv.) was used as the coupling reagent, no dramatic
differences in either conversion or reaction time were
observed. For practical reasons, DCC was chosen as the coup-
ling agent in the optimization study, in which the reaction
conditions for the first coupling step used a 1 : 1 ratio of both
substrates (1a and 2a), with a combination of DCC (1.2 equiv.)
and DMAP (0.3 equiv.) in THF at room temperature.
Under these conditions, the model reaction yielded the
amide 3aa along with a trace amount of a fluorescent molecule
6aa, as observable on the TLC plate. The chemical identity of
6aa was initially determined by mass spectrometry analysis as
the expected compound with a bimane structure (D), since the
mass data of the compound agreed closely with the expected
mass data of bimane [MS (EI, m/z): 282.2 (M+)]. However, after
a close inspection of its 1H-NMR spectrum, we discovered that
the phenyl ring protons of the unknown structure resonated at
distinctly different frequencies, which contradicted the
1H-NMR data of the reference bimane derivative shown in the
literature.10 In fact, the phenyl ring protons of a symmetric
bimane structure were expected to resonate at almost the same
frequencies, a surprising observation that casts doubt on an
alternative molecular structure (Fig. 3).
To further inspect the structure of the unknown product,
we performed X-ray diffraction analysis on the single crystal of
6aa recrystallized over a cold hexane–DCM solvent system. For-
tunately, the fluorescent molecule, first assigned as a bimane
structure (D), was in fact a γ-pyranopyrazole derivative (6aa)
bearing the chemical structure displayed in Fig. 4.
Having unambiguously clarified the chemical identity of
the fluorescent compound as a pyrazole-fused γ-pyrone deriva-
tive and having optimized the conditions of the first reaction,
we next focused our attention on intramolecular cyclisation.
To this end, the amide 3aa prepared in situ was treated
respectively with a series of bases, including Cs2CO3, K2CO3,
DBU, and Et3N (1 equiv. of each), and added to the reaction
Scheme 1 Retrosynthetic approach for the preparation of
γ-pyranopyrazole.
Fig. 2 Optimized reaction conditions for the amide formation step.
Fig. 3 Comparative 1H-NMR spectra of (a) bimane (D) and (b) com-
pound E (6aa).
Fig. 4 X-ray diffraction analysis of compound 6aa with thermal ellip-
soids drawn at the 40% probability level.
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vessel soon after the starting materials were entirely con-
sumed, as revealed on the TLC plate (ca. 0.5–1.0 hours). Only
in the presence of Cs2CO3 (1 equiv.) in the one-pot protocol,
the cyclisation step proceeded smoothly and produced 6aa in a
good yield (82%); (Table 1, entry 3). Consistent with other
reports,11a–c Cs2CO3 showed superior activity compared to
other bases due to its mild base strength. Increasing the equi-
valency of Cs2CO3 showed no observable contribution to
improving the yields (Table 1, entry 6), whereas lowering the
amount of the base to catalytic levels (0.1 equiv.) negatively
affected both the reaction yield and time (Table 1, entry 5).
Importantly, in the presence of acidic reagents such as
CF3COOH (Table 1, entry 11) no cyclisation was monitored,
while at elevated temperatures the cyclisation could be trig-
gered to some extent (Table 1, entry 12).
Transition metal-catalysed alkyne activation reactions have
been common in synthetic chemistry and have attracted great
attention during the last decade. With this in mind, we aimed
to substitute the base with a Lewis acidic metal species in the
hope of catalysing the intramolecular cyclisation step more
efficiently than with any other base. Surprisingly, none of the
tested alkynophilic metal species had enough power to catalyse
intramolecular cyclisation. Namely, in the presence of alkyno-
philic metal species such as AuCl3, CuI, AgSbF6 and Pd(OAc)2,
no cyclisation occurred, likely due to the deactivation of the
metal species by either the DMAP or DCC reagents present in
the one-pot environment (Table 2, entries 6–9). In fact,
employing a base11 instead of a metal species for a chemical
process is advantageous for mitigating environmental pro-
blems such as metal pollution and metal toxicity.
Given these results, we eventually established that the most
suitable coupling partners for the one-pot synthetic protocol
were DCC and DMAP, the solvent was THF, and the reagent
driving cyclisation to completion was Cs2CO3 (Table 1, entry 2).
The reaction time for the one-pot reaction at room temperature
varied from 3 to 6 h, depending on the structure of the sub-
strates used (Table 2).
With the optimized conditions in hand, we next explored
the scope and limitations of the sequential amide formation
and cyclisation process by testing the reactions of various pro-
piolic acid derivatives (2a–k) with a range of pyrazolone deriva-
tives (1a–e) (Table 2). The substrate scope is shown in Table 2.
A variety of aryl propiolic acid derivatives bearing electron-
donating or -withdrawing groups as substituents on the 2-, 3-,
and 4-positions of the aryl ring underwent reactions smoothly
and yielded the desired compound in moderate to good yields.
Electronic properties of the substituents displayed a slight
effect on both the yield and reaction time; namely, yields for
substrates bearing electron-donating groups on the aryl ring
were slightly higher. Although the cyclisation of aliphatic pro-
piolic acid derivatives (2b–d) proceeded as well, the rate of
cyclisation and the reaction yields were distinctly lower than
that of aryl propiolic acid derivatives (2a, 2e–k).
Based on the experimental and computational results, we
proposed a reasonable mechanism for the formation of γ-pyrano-
pyrazole as outlined in Scheme 2. Mechanistically, the reac-
tion proceeds by way of a two-step consecutive process, the first
step of which is a classical C–N coupling. Compound 3, formed
in the first step, subsequently undergoes a base-mediated intra-
molecular 6-endo-dig ring closure from the oxygen atom over the
alkyne to yield γ-pyranopyrazole (6) (Scheme 2).
Table 2 Substrate scope for the one-pot process
Entry 1 (R1) 2a (R2) 6
Timec
(h)
Yieldb
(%)
1 1a (Ph) 2a (Ph) 6aa 3 82
2 1a 2b (H) 6ab 3 25
3 1a 2c (Me) 6ac 3 57
4 1a 2d (n-Pent) 6ad 3 50
5 1a 2e (4-MeC6H4) 6ae 3 80
6 1a 2f (4-MeOC6H4) 6af 3 85
7 1a 2g (4-ClC6H4) 6ag 3 74
8 1a 2h (2-MeC6H4) 6ah 4 73
9 1a 2i (3-MeC6H4) 6ai 4 75
10 1a 2j (3,5-(CF3)2C6H3) 6aj 5 73
11 1b (Me) 2a (Ph) 6ba 5 47
12 1b 2e (4-MeC6H4) 6be 6 50
13 1b 2j (3,5-(CF3)2C6H3) 6bj 6 45
14 1c (p-tolyl) 2a 6ca 4 85
15 1d (p-Cl-Ph) 2a 6da 4 90
16 1e (m-tolyl) 2a 6ea 4 76
17 1a 2k (4-MeOCOC6H4) 6ak 4 81
a 1 equivalent of the reagents, otherwise indicated. b Isolated yields.
c Reaction time at room temperature.
Table 1 Effect of certain bases and metal ion additives on the cyclisa-
tion of 3aa
Entry Reagentsa Timec (h) Yieldb 6aa (%)
1 Et3N 3 34
2 K2CO3 4 60
3 Cs2CO3 3 82
4 DBU 3 38
5 Cs2CO3 (0.1 equiv.) 8 40
6 Cs2CO3 (2 equiv.) 3 85
7 AuCl3 (0.1 equiv.) 24 <1 (trace)
8 AgSbF6 (0.1 equiv.) 24 Trace
9 CuI (0.1 equiv.) 24 Trace
10 Pd(OAc)2 (0.1 equiv.) 24 Trace
11 CF3COOH (3 equiv.) 8 Trace
12 Noned 6 25
13 DMAPe 4 35
a 1 equivalent of the reagents, otherwise indicated. b Isolated yields.
c Reaction time at room temperature. dWithout any additional reagent
at 80 °C. e 3 equiv. of DMAP.
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Selective formation of the γ-pyranopyrazole ring over the
bimane ring was computationally investigated to explain the
product selectivity (Scheme 2). Geometrical parameters were
optimized with the density-functional theory (B3LYP/
6-311G++(d,p)).12–14 Reaction energies and activation energy
barriers are shown in Table S2 (see the ESI†), and the potential
energy profile of the cyclisation step is shown in Fig. 5.
The TS (transition state) of 3x/4x and 3y/4y are considered to
be the rate-determining steps for structures 7 and 6, respect-
ively. Calculations confirmed that the activation energy barrier
for forming intermediate 4x was considerably higher than 4y
(Table S2, entries 10 and 14 and see the ESI†); namely, the
difference between the reaction barriers of 4x and 4y was calcu-
lated to be 7.1 kcal mol−1 (Fig. 5). Furthermore, the TS theory
rate constants at room temperature were calculated to be 5.0 ×
10−4 s−1 and 47 s−1 for 4x and 4y, respectively (Table S2, see the
ESI†). Accordingly, compound 6 is the kinetically favourable
product, which also reveals that compound 7 was unobservable.
The electrostatic potential map (EPM) of 3cb (R1 and R2 = H)
was calculated to investigate the resonance hybrid structures that
significantly contributed to the structure of compound 3. We sur-
mised that the resonance structure with the negatively charged
oxygen atom was the dominant hybrid of 3cb. To verify this
assumption, we considered the structure of 3cb (Fig. S1, see the
ESI†), which shows that the C–O bond length (1.231 Å) in the
pyrazolidine fragment is noticeably longer than that of the
regular C–O double bond (1.222 Å). As such, the C–O bond of the
pyrazolidine fragment has a single-bond character, which
accounts for the intermolecular cyclisation over the oxygen atom.
Also, the EPM of 3cb (Fig. 6) demonstrates that the negative
charge is located on the oxygen atom of the pyrazolidine ring. In
short, a favourable geometry associated with the formation of
γ-pyrone (6) never allowed compound 3 to undergo a 5-exo-dig
hydroamination ring closure necessary to yield a bimane ring (7).
Most of the γ-pyrone derivatives synthesized herein dis-
played strong fluorescence emission under ultraviolet light.
For this reason, we further determined the photophysical pro-
perties of all new γ-pyrone derivatives by measuring their
absorption and emission wavelengths, fluorescence quantum
yields, and absorption coefficients. Table S1† summarizes all
these properties for all new γ-pyrone derivatives. Among them,
compounds 6aa, 6ad and 6ag displayed exceptional photo-
physical features presenting great potential for use in appli-
cations for biochemical labelling and light-emitting devices.
Conclusions
In summary, we developed a one-pot, two-step synthetic
method for constructing a range of highly emissive γ-pyrano-
pyrazole derivatives. Remarkably, this one-pot system is based
on a transition metal-free synthetic protocol involving the use
of an inorganic base (e.g. Cs2CO3) to promote an intra-
molecular 6-endo-dig cyclisation process. Based on compu-
tational studies, we ultimately proposed a reasonable
mechanism for product selectivity.
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